Actinogen Medical Ltd CEO Dr Steven Gourlay talked with Proactive about the topline results from the company's XanaMIA clinical trial, which...
Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF) is entering a key commercial phase in the...
Anteris Technologies Ltd (ASX:AVR) (OTCMKTS:AMEUF) (FRA:DDF) is aiming to revolutionise the...
A personalised mRNA cancer vaccine jointly developed by Moderna Inc (NASDAQ:MRNA, XETRA:0QF) and...
Actinogen Medical Ltd CEO Dr Steven Gourlay talked with Proactive about the topline results from the company's XanaMIA clinical trial, which evaluated its investigational Alzheimer's disease treatment Xanamem. The study revealed encouraging signs of disease slowing in patients aged...